Submission of abstracts

Deadline for receipt of abstracts – 31st March 2012

Abstracts are now invited for oral and poster presentations for the 2012 Cancer Outcomes Conference being organised by the NCIN and UKACR.

Oral presentations will be allocated 10 minutes, not including time for questions and discussion, Poster presenters will have the opportunity to present their posters during the lunch and refreshment breaks. Prizes will be awarded for the best posters.

Abstracts and presenting author details will be published in the conference brochure.

If you have any questions please do not hesitate to contact conference@ncin.org.uk.

Abstract submission guidelines

All abstracts must be submitted online using this form and must adhere to the guidelines outlined below. Submissions that do not follow the guidelines, that are incomplete, or that are received after the closing date may not be considered for review.

Abstracts must not exceed a maximum of 300 words.

An author may submit more than one application as long as the content of each abstract is different.

All accepted abstracts will be published as submitted - please check carefully to avoid spelling mistakes.

The presenting author of the abstract must register for and attend the conference; separate registration is required. Please indicate who the presenting author will be in your submission. Authors may be asked to present on either day of the conference.

Submission of abstracts to the NCRI Cancer Conference

The eighth NCRI Cancer Conference, will take place on 4 - 7 November 2012 at the BT Convention Centre, Liverpool. Authors submitting their work to the NCIN and UKACR's Cancer Outcomes Conference may mark their abstracts to be considered for presentation at the NCRI Cancer Conference without a separate submission.

The NCRI Cancer Conference is the leading international oncology meeting in the UK and delivers a pioneering programme showcasing high-quality data and a multi-disciplinary approach to cancer research from basic research to prevention, diagnosis, treatment and survivorship. The world-renowned speakers and excellent networking opportunities attract around 2,000 delegates representing the whole oncology field from researchers and data managers to clinicians, nurses and policy makers. View the 2012 Preliminary Programme